Jordana Jampel

DocwireNews

In a new study published in <a href="https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2828637?resultClick=1">JAMA Network Open</a>, researchers assessed whether individuals diagnosed with advanced breast cancer are more likely to have prevalent cardiovascular disease (CVD) compared with those diagnosed with early-stage breast cancer.
The study used data from the Surveillance, Epidemiology, and End Results (SEER)-Medicare linked databases from 2009 to 2020 and included a cohort of 19,292 control-matched individuals diagnosed with invasive breast cancer. The participants were at least 66 years old, with a median age of 73 years (interquartile range, 70-79); 9,478 individuals (49.1%) had prevalent CVD.
Propensity score–matched, multivariable-adjusted models revealed that individuals with locally advanced or metastatic breast cancer at diagnosis had statistically significantly increased odds of prevalent CVD (odds ratio [OR], 1.10; 95% CI, 1.03-1.17; P=.007). This association was observed among individuals with hormone receptor–positive (OR, 1.11; 95% CI, 1.03-1.19; P=.006) breast cancer but not those with hormone receptor–negative (OR, 1.02; 95% CI, 0.86-1.21; P=.83) breast cancer. ORs were directionally consistent on separate examination of locally advanced (OR, 1.09; 95% CI, 1.02-1.17; P=.02) and metastatic (OR, 1.20; 95% CI, 0.94-1.54; P=.15) disease, among all receptor subtypes.
“This retrospective case-control study found an association between prevalent CVD and more advanced stage of breast cancer at diagnosis, independent of factors associated with delayed diagnosis and shared risk. Further studies are needed to determine whether individuals with CVD would benefit from personalized screening approaches,” the researchers concluded.
Source
<a href="https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2828637?resultClick=1">JAMA Network Open</a>

Correlation Between Breast Cancer Diagnosis Stage and Prevalence of Heart Disease

Breast Cancer News

Cecilia Brown

FDA Grants Priority Review to New Drug Application for Sunvozertinib in NSCLC

EGFR+ NSCLC

Association Between T2D, CVD and Sugary Drinks Is Prominent Around Globe

Diabetes

Latest News

The study used SEER data of nearly 20,000 cases. 

About Us

Editorial Policy

Advertising

eNewsletters

Contribute

Contact Us

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

Mesothelioma

Non-Small Cell Lung Cancer

Small Cell Lung Cancer

Squamous Cell Lung Carcinoma

Lung Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

The Oncology Brothers

Rheumatology Rounds With Dr. Maheswaranathan

Healthcare Unfiltered

The Fellow on Call

Partners

Hurricanes & Health Care

Career Center

Expert Interviews

Subscribe